The Limited Times

Now you can see non-English news...

The giants of medical cannabis storm France

2021-01-27T20:40:54.552Z

Six suppliers have been selected for a first experiment which will be launched within two months. Cannabis manufacturers are in the starting blocks. In two months, a first experiment with medical cannabis will start in France. It will make it possible to provide, free of charge, and on prescription, 3000 patients suffering from serious illnesses (certain forms of epilepsy, neuropathic pain, side effects of chemotherapy, palliative care or multiple sclerosis) in a situation of treatment failure



Cannabis manufacturers are in the starting blocks.

In two months, a first experiment with medical cannabis will start in France.

It will make it possible to provide, free of charge, and on prescription, 3000 patients suffering from serious illnesses (certain forms of epilepsy, neuropathic pain, side effects of chemotherapy, palliative care or multiple sclerosis) in a situation of treatment failure, either because of insufficient relief, or because of poor tolerance of existing drugs.

Pharmacies will be at the heart of the system.

The National Medicines Safety Agency (ANSM) has just unveiled the list of six suppliers selected as part of a call for tenders launched in the fall.

Each manufacturer won a market segment, in tandem with a distributor based in France.

Alongside the Canadian heavyweights, Aurora (dried cannabis flowers) and Tilray (oil), are the Israeli Panaxia (capsules) and the Australian Little

This article is for subscribers only.

You have 75% left to discover.

Subscribe: 1 € the first month

Can be canceled at any time

I ENJOY IT

Already subscribed?

Log in

Source: lefigaro

All business articles on 2021-01-27

You may like

Business 2021-01-27T20:40:54.552Z
Life/Entertain 2020-09-15T18:26:19.262Z

Trends 24h

Business 2021-03-03T09:40:33.213Z

Latest

© Communities 2019 - Privacy